Nasdaq Biotechnology Index
E31609
The Nasdaq Biotechnology Index is a stock market index that tracks the performance of biotechnology and pharmaceutical companies listed on the Nasdaq stock exchange.
All labels observed (3)
| Label | Occurrences |
|---|---|
| Nasdaq Biotechnology Index canonical | 3 |
| NASDAQ-100 Biotechnology Index | 1 |
| Nasdaq index family | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T224945 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Nasdaq Biotechnology Index Context triple: [NASDAQ, hasIndex, Nasdaq Biotechnology Index]
-
A.
Nasdaq Composite Index
The Nasdaq Composite Index is a stock market index that tracks the performance of all common stocks listed on the Nasdaq Stock Market, with a heavy weighting toward technology and growth-oriented companies.
-
B.
NASDAQ-100 Index
The NASDAQ-100 Index is a stock market index comprising 100 of the largest non-financial companies listed on the Nasdaq Stock Market, heavily weighted toward the technology sector.
-
C.
S&P 500 Index
The S&P 500 Index is a major U.S. stock market benchmark that tracks the performance of 500 large publicly traded companies listed on American exchanges.
-
D.
Dow Jones Industrial Average
The Dow Jones Industrial Average is a major U.S. stock market index that tracks the performance of 30 large, publicly traded blue-chip companies.
-
E.
NYSE Composite
The NYSE Composite is a stock market index that tracks the performance of all common stocks listed on the New York Stock Exchange, providing a broad measure of the exchange’s overall market activity.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Nasdaq Biotechnology Index Target entity description: The Nasdaq Biotechnology Index is a stock market index that tracks the performance of biotechnology and pharmaceutical companies listed on the Nasdaq stock exchange.
-
A.
Nasdaq Composite Index
The Nasdaq Composite Index is a stock market index that tracks the performance of all common stocks listed on the Nasdaq Stock Market, with a heavy weighting toward technology and growth-oriented companies.
-
B.
NASDAQ-100 Index
The NASDAQ-100 Index is a stock market index comprising 100 of the largest non-financial companies listed on the Nasdaq Stock Market, heavily weighted toward the technology sector.
-
C.
S&P 500 Index
The S&P 500 Index is a major U.S. stock market benchmark that tracks the performance of 500 large publicly traded companies listed on American exchanges.
-
D.
Dow Jones Industrial Average
The Dow Jones Industrial Average is a major U.S. stock market index that tracks the performance of 30 large, publicly traded blue-chip companies.
-
E.
NYSE Composite
The NYSE Composite is a stock market index that tracks the performance of all common stocks listed on the New York Stock Exchange, providing a broad measure of the exchange’s overall market activity.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biotechnology stock index
ⓘ
pharmaceutical stock index ⓘ stock market index ⓘ |
| calculationMethod | market capitalization weighted ⓘ |
| currency | US dollar ⓘ |
| dataVendorCode | ^NBI ⓘ |
| excludes | securities listed on other exchanges ⓘ |
| focusesOnIndustry |
health care
ⓘ
life sciences ⓘ |
| geographicFocus |
United States of America
ⓘ
surface form:
United States
|
| hasAbbreviation | NBI ⓘ |
| hasCategory |
industry index
ⓘ
sector index ⓘ |
| hasComponentType |
American Depositary Receipts
ⓘ
common stocks ⓘ |
| hasConstituentSelection | rules-based ⓘ |
| hasRebalancingFrequency | quarterly ⓘ |
| hasReconstitutionFrequency | annually ⓘ |
| hasTickerSymbol | NBI ⓘ |
| includesCompaniesListedOn |
Nasdaq Global Market
ⓘ
Nasdaq Global Select Market ⓘ |
| includesCompanyType |
biopharmaceutical companies
ⓘ
biotechnology research and development firms ⓘ drug manufacturers ⓘ |
| includesOnly | Nasdaq-listed securities ⓘ |
| isBenchmarkFor |
biotechnology sector performance
ⓘ
pharmaceutical sector performance ⓘ |
| isCalculatedIn | real time ⓘ |
| isPartOf |
Nasdaq Biotechnology Index
self-linksurface differs
ⓘ
surface form:
Nasdaq index family
|
| isPublishedBy |
NASDAQ
ⓘ
surface form:
Nasdaq
|
| isUsedAsUnderlyingFor |
derivative products
ⓘ
exchange-traded funds ⓘ index funds ⓘ |
| isUsedBy |
fund managers
ⓘ
institutional investors ⓘ retail investors ⓘ |
| listedOn |
NASDAQ
ⓘ
surface form:
Nasdaq Stock Market
|
| marketFocus | equities ⓘ |
| operatedBy |
NASDAQ
ⓘ
surface form:
Nasdaq, Inc.
|
| provider |
NASDAQ
ⓘ
surface form:
Nasdaq
|
| regionOfExchange |
United States of America
ⓘ
surface form:
United States
|
| requires |
minimum average daily trading volume for inclusion
ⓘ
minimum market capitalization for inclusion ⓘ seasoning period for newly listed securities ⓘ |
| sectorFocus |
biotechnology
ⓘ
pharmaceuticals ⓘ |
| tracks |
biotechnology companies
ⓘ
pharmaceutical companies ⓘ |
| weightingMethod | modified market capitalization weighting ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Nasdaq Biotechnology Index Description of subject: The Nasdaq Biotechnology Index is a stock market index that tracks the performance of biotechnology and pharmaceutical companies listed on the Nasdaq stock exchange.
Referenced by (5)
Full triples — surface form annotated when it differs from this entity's canonical label.